Our programme continues to produce high value outcomes, investing in motivated people as a foundation and building upon their passion and knowhow to forge meaningful relationships and to advance health technology innovations.
SSB fellows continue to pursue a career in healthcare post-fellowship in four key paths: CEOs/Co-Founders, Project Managers, Business Development Managers and Clinician Innovators. A significant proportion of SSB Fellows play enabling roles to plug translation and commercialization gaps in the local ecosystem. Those that remain in clinical institutions and academia continue to support training and project origination in their workplace.
Arising from our talent development initiatives and as a natural evolution of the programme, SSB’s Fellow and class alumni have witnessed increasing success in its spin-off output, with 2 technologies reaching >1k patients. A respectable innovation pipeline of 31 technical disclosures filed, 20+ funded projects (>S$5M funding) and 7 spin-offs has established SSB not only as a training programme but also as a high fidelity spin-off platform and a source of deal-flow for investors/incubators.
SSB's innovation pipeline has also seen an increasing shift towards digital and connected health products and services. The strong foundations in Biodesign methodology serves to increase the chance of project success upon spinoff. This seeding of innovation projects and formation of start-ups is seen as the strongest validation of our training programme.
Find Out More
A vibrant ecosystem is vital in order to continue nurturing talent, both during and post-training. With this view in mind, SSB has been playing a role of an enabler to bring together various players of the medtech ecosystem in Singapore and Asia. In addition, initiatives like the regional clinical immersion has allowed SSB to spread its wings outside Singapore.